On September 23, 2019 Oncolytics Biotech Inc. (NASDAQ:ONCY)(TSX:ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, reported that it will be presenting on the Company’s pipeline progress, robust data catalysts and operational milestones, at the following investor conferences (Press release, Oncolytics Biotech, SEP 23, 2019, View Source [SID1234539687]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Ladenburg Thalmann Healthcare Conference
Location: Hotel Sofitel, New York, NY
Date: September 24th, 2019
Presentation Time: 11:00 AM ET
Presenter: Dr. Matt Coffey, President & CEO
Webcast: View Source
BIO Investor Forum
Location: The Westin St. Francis, San Francisco, CA
Date: October 23rd, 2019
Presentation Time: 10:30 AM PT
Presenter: Dr. Matt Coffey, President & CEO